Hepatitis C

• CLINICAL_TRIALS trial_result · 2019-06-05
  Clinical Trial Update: Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

  An observational study in Austria evaluating Paritaprevir/ritonavir–ombitasvir ± dasabuvir ± ribavirin in patients with chronic hepatitis C;…

• CLINICAL_TRIALS trial_result · 2019-06-04
  Clinical Trial Update: Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy [Phase 2]

  A Phase 2 trial evaluating interferon-free treatment for Hepatitis C in adults co-infected with HIV on antiretroviral therapy was terminated…

• CLINICAL_TRIALS trial_result · 2019-06-03
  Clinical Trial Update: A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir [Phase 4]

  Phase 4 trial update for Grazoprevir plus Elbasvir in G1b chronic hepatitis C patients with CKD stage 3; completed with posted results.

• CLINICAL_TRIALS trial_result · 2019-06-03
  Clinical Trial Update: HCV-HIV Co-infected Patient Cohort in Thailand [Phase 4]

  Phase 4 trial completed for HCV-HIV co-infected patients in Thailand; results posted in 2019.

• CLINICAL_TRIALS trial_result · 2019-05-29
  Clinical Trial Update: Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) [Phase 2]

  Phase 2 clinical trial update for a short-duration combination therapy (daclatasvir, asunaprevir, BMS-791325, and sofosbuvir) in chronic hep…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2019-05-23
  Clinical Trial Update: Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus [Phase 4]

  Phase 4 clinical trial evaluating hyalurnic acid levels in β-thalassemic children treated for hepatitis C.

• CLINICAL_TRIALS trial_result · 2019-05-21
  Clinical Trial Update: Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir [Phase 3]

  Phase 3 trial evaluating peginterferon lambda-1a and ribavirin with telaprevir for hepatitis C; trial completed with results posted.

• CLINICAL_TRIALS trial_result · 2019-05-17
  Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

  Clinical trial update reports real-world effectiveness of paritaprevir/ritonavir-ombitasvir +/- dasabuvir +/- ribavirin with patient support…

• CLINICAL_TRIALS trial_result · 2019-05-10
  Clinical Trial Update: Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection [Phase 1, Phase 2]

  A phase 1/2 clinical trial evaluated autologous dendritic cell vaccine for chronic hepatitis C infection; the study is completed with result…

• CLINICAL_TRIALS trial_result · 2019-05-07
  Clinical Trial Update: LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients [Phase 4]

  Phase 4 trial update on using Sofosbuvir/Ledipasvir for Hepatitis C in liver transplant recipients; results posted following completion.

• CLINICAL_TRIALS trial_result · 2019-05-06
  Clinical Trial Update: The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

  An observational study in Ireland assessing the effectiveness of ABT-450/r (ombitasvir) ± dasabuvir ± ribavirin for chronic hepatitis C; stu…

• CLINICAL_TRIALS trial_result · 2019-05-06
  Clinical Trial Update: Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

  Observational study evaluating effectiveness of paritaprevir/ritonavir-ombitasvir ± dasabuvir ± ribavirin in chronic hepatitis C genotypes 1…

• CLINICAL_TRIALS trial_result · 2019-05-02
  Clinical Trial Update: Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection [NA]

  Clinical trial evaluating nurse case management to improve Hepatitis C care in individuals co-infected with HIV has completed with results p…

• CLINICAL_TRIALS trial_result · 2019-04-30
  Clinical Trial Update: Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection [Phase 2]

  Phase 2 trial assessing safety and efficacy of Sofosbuvir + Ribavirin in adolescents and children with genotype 2 or 3 chronic hepatitis C i…

• CLINICAL_TRIALS trial_result · 2019-04-24
  Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics [Phase 4]

  Phase 4 trial evaluating 16 vs 24 weeks of Daclatasvir/Sofosbuvir/Ribavirin in genotype 3 hepatitis C cirrhotics; completed with results pos…

• CLINICAL_TRIALS trial_result · 2019-04-24
  Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection [Phase 2]

  Phase 2 trial evaluating safety and efficacy of ledipasvir/sofosbuvir fixed-dose combination with or without ribavirin in adolescents and ch…

• CLINICAL_TRIALS trial_result · 2019-04-09
  Clinical Trial Update: Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016) [Phase 2, Phase 3]

  A Phase 2/3 trial comparing PEG-Intron (polyethylene glycol-interferon alfa-2b) to interferon alfa-2b in chronic hepatitis C completed with …

• CLINICAL_TRIALS trial_result · 2019-04-03
  Clinical Trial Update: Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study [Phase 3]

  Phase 3 trial update evaluating the safety and efficacy of a fixed-dose combination (sofosbuvir/velpatasvir/voxilaprevir) for 12 weeks in ad…

• CLINICAL_TRIALS trial_result · 2019-03-27
  Clinical Trial Update: Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

  Clinical trial update on the effectiveness of Paritaprevir/ritonavir-ombitasvir +/- dasabuvir +/- ribavirin in chronic hepatitis C patients …

• CLINICAL_TRIALS trial_result · 2019-03-27
  Clinical Trial Update: Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience [Phase 2]

  Phase 2 trial evaluating safety, tolerability, and efficacy of sofosbuvir/velpatasvir/voxilaprevir in patients with prior DAA experience for…

• CLINICAL_TRIALS trial_result · 2019-03-22
  Clinical Trial Update: Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)

  A completed clinical trial assessing cardiovascular and renal health in patients with Hepatitis C, with results posted in 2019.

• CLINICAL_TRIALS trial_result · 2019-03-19
  Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection [Phase 3]

  A Phase 3 trial of a fixed-dose combination of Sofosbuvir/Velpatasvir for 12 weeks in adults with chronic hepatitis C virus infection has co…

• CLINICAL_TRIALS trial_result · 2019-03-14
  Clinical Trial Update: An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C

  Observational study assessing dual and triple therapies based on Pegasys (peginterferon alfa-2a) in chronic hepatitis C; study completed wit…

• CLINICAL_TRIALS trial_result · 2019-03-04
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment [Phase 3]

  Phase 3 trial evaluating Glecaprevir/pibrentasvir in adults with chronic HCV genotype 1-6 infection and renal impairment has completed with …

• CLINICAL_TRIALS trial_result · 2019-02-27
  Clinical Trial Update: A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use [Phase 2]

  Phase II trial update evaluating sofobuvir and GS-5816 for chronic hepatitis C in people with recent injection drug use; study completed.